Results 61 to 70 of about 52,364 (182)
Physiotherapy Research International, Volume 29, Issue 4, October 2024.Abstract Introduction Frailty is significantly correlated with a higher incidence of medical complications during hospitalization after esophagectomy. As frailty is thought to be a reversible condition, improving the reserve capacity through preoperative physical therapy is expected to reduce the risk of postoperative pulmonary complications (PPCs ...
Yusuke Takahashi +6 more
wiley +1 more source
Effects of olopatadine hydrochloride on the release of thromboxane B2 and histamine from nasal mucosa after antigen–antibody reaction in guinea pigs [PDF]
, 2001 BackgroundVarious mediators, such as thromboxane (TX) A2, peptide leukotrienes (P-LT) and histamine, are involved in allergic nasal obstruction. The aim of the present study was to investigate the mechanism whereby olopatadine hydrochloride, a novel anti-
Ishii, Akio +4 more
core +1 more source
Veterinary Ophthalmology, Volume 27, Issue 5, Page 396-405, September 2024.Abstract Objective The objective of the study was to evaluate the efficacy of a once a day, over the counter antihistamine eye drop, 0.7% olopatadine hydrochloride, in treating or preventing experimentally induced allergic conjunctivitis in dogs.
Esther T. Mamo +2 more
wiley +1 more source
, 2005 Purpose: The aim of this study was to investigate the effect of topical 0.1% olopatadine hydrochloride on goblet cell density, clinical signs, and symptoms of patients with vernal ...
Yeniad, B +3 more
core +1 more source
Asian Journal of Medical SciencesBackground: Allergic conjunctivitis (AC) affects 10–20% of the Indian population, necessitating cost-effective treatment strategies. Aims and Objectives: We aimed to evaluate the comparison between the pharmacoeconomic profiles of olopatadine ...
Sudipto Chatterjee +3 more
doaj +1 more source
Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment [PDF]
, 2017 Takanori Mizoguchi,1 Mineo Ozaki,2 Nobuchika Ogino3 1Mizoguchi Eye Clinic, Ophthalmology, Sasebo, Japan; 2Ozaki Eye Hospital, Ophthalmology, Miyazaki, Japan; 3Nishigaki Eye Clinic, Ophthalmology, Nagoya, Japan Purpose: To evaluate the efficacy and ...
Ozaki M +5 more
core +1 more source
Clinical Ophthalmology, 2012 Craig F McCabe, Shannon E McCabeMcCabe Vision Center, Murfreesboro, TN, USABackground: The aim of this study was to compare patient-perceived relief of ocular itch, nasal symptoms, and eye drop comfort when allergic conjunctivitis was treated with ...
McCabe CF, McCabe SE
doaj
ALLERGIC EYE DISEASES IN CHILDREN. MODERN VIEW ON PATHOGENESIS AND TREATMENT
Oftalʹmologiâ, 2017 The prevalence off allergic diseases has been significantly increased among adults and children during last 30-40 years. International study has shown that the frequency of atopy in developed countries, including Russia, is higher than in ...
E. Y. Markova +2 more
doaj +1 more source
Japanese Journal of Pharmacology, 2002 Olopatadine hydrochloride (olopatadine, 11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride) is a novel antiallergic/histamine H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories. Oral administration of olopatadine at doses of 0.03 mg/kg or higher inhibited the symptoms of
Ohmori, Kenji +6 more
openaire +3 more sources
Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R
Allergy, Asthma & Clinical Immunology, 2020 MP-AzeFlu is relatively new a pharmaceutical drug used in the treatment of allergic rhinitis. It is comprised of azelastine hydrochloride (AZE), a potent histamine-H1-receptor antagonist and fluticasone propionate (FP), corticosteroid.
Sandra Ekstedt +2 more
doaj +1 more source